Accueil Biotechnology Next-Generation Antibody Therapeutics Market Analysis, Share and Future Scope

Next-Generation Antibody Therapeutics Market Analysis, Share and Future Scope

0
0
18
Next-Generation Antibody Therapeutics Market

The global next-generation antibody therapeutics market is growing due to increasing popularity of antibody-drug conjugate (ADC) and increasing number of collaborations for R&D in next-generation antibody therapeutics. In addition, growing prevalence of chronic diseases and increase in research and development investments by various organizations for production of improved products further encourages the growth of global next-generation antibody therapeutics market. Furthermore, increase in healthcare expenditure and technological advancements in antibody therapeutics have led to the development of more efficient antibody therapeutics, which is resulting in increased demand for next-generation antibody therapeutics.

Browse report sample at: https://www.psmarketresearch.com/market-analysis/next-generation-antibody-market/report-sample

Governments of various countries are involved in taking initiatives for improving healthcare facilities, and making next-generation antibody therapeutics affordable. This is increasing the demand for next-generation antibody therapeutics. The increasing global gross domestic product (GDP) and growing healthcare expenditure have created a positive impact on the growth of the next-generation antibody therapeutics market. Also, in comparison to traditional antibodies, the next-generation antibody therapeutics is more effective in the treatment of various diseases, such as cancer, autoimmune disorders, and inflammatory diseases. This is attracting various pharmaceutical and biotechnology companies to increase their investment in the R&D of next-generation antibody therapeutics.

However, certain restraints such as high cost of next-generation antibody therapeutics, stringent regulatory requirements and time-consuming approval process for new drugs are hindering the market growth. North America next-generation antibody therapeutics market is expected to witness the fastest growth of CAGR 46.2% globally, during the period 2015 – 2020.

Browse report at: https://www.psmarketresearch.com/market-analysis/next-generation-antibody-market

The key companies operating in the global next-generation antibody therapeutics market include Seattle Genetics Inc., F. Hoffmann-La Roche Ltd, ImmunoGen Inc., Pfizer Inc., Amgen Inc., Biogen, Kyowa Hakko Kirin Co. Ltd., Bristol-Myers Squibb Company, Xencor Inc., AstraZeneca PLC., Dyax Corp., Takeda Pharmaceuticals Company Limited and Bayer AG.

Source: P&S Intelligence

Charger d'autres articles liés
Charger d'autres écrits par healthcarenewswire
Charger d'autres écrits dans Biotechnology

Laisser un commentaire

Consulter aussi

Saudi Arabia Microbiology Cell Culture Market Analysis with Key Players, Trends and Forecasts by 2023

Saudi Arabian microbiology cell culture market is forecasted to reach $38.7 million by 202…